Related Experiment Videos
Enhanced external counterpulsation
1Mount Elizabeth Hospital, Singapore. cardiac@singnet.com.sg
Insights
Enhanced external counterpulsation (EECP) improves heart function and blood flow in coronary artery disease patients. This noninvasive therapy offers a cost-effective treatment option, especially for those with severe disease or limited revascularization possibilities.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Noninvasive Cardiology
Background:
- Coronary artery disease (CAD) poses significant challenges in myocardial perfusion and cardiac workload.
- Existing treatments may not be suitable for all patients, particularly those with severe or diffuse disease.
Purpose of the Study:
- To evaluate the efficacy of enhanced external counterpulsation (EECP) as a therapeutic option for CAD.
- To assess the impact of EECP on myocardial perfusion and cardiac workload.
Main Methods:
- EECP is a noninvasive technique.
- Hemodynamic effects were assessed in recent trials.
- Functional capacity and myocardial perfusion were evaluated using stress testing and radionuclide imaging.
Main Results:
- Beneficial hemodynamic effects of EECP have been documented.
- Improvements in functional capacity were observed.
- Enhanced myocardial perfusion was demonstrated through imaging studies.
Conclusions:
- EECP is a viable noninvasive treatment for increasing myocardial perfusion and reducing cardiac workload in CAD patients.
- It represents a potential therapeutic choice for patients with severe diffuse disease or when repeat revascularization is not feasible.
- The cost-effectiveness of EECP makes it accessible, including in developing countries.
Abstract:
Enhanced external counterpulsation is a noninvasive technique designed to increase myocardial perfusion and reduce cardiac workload in patients with coronary artery disease. Recent trials have documented beneficial hemodynamic effects. Stress testing and radionuclide imaging have demonstrated improvements in functional capacity and myocardial perfusion. This procedure may be the therapeutic choice for patients with severe diffuse disease or in whom repeat revascularization is not possible. The relatively low cost of the technique makes it feasible for patients in developing countries.